Physician profile
Daniel Margolis
NPI 1811939788
$5,162.64
in general payments reported to CMS, 2019-2025
7 companies · $3,616 in 2025
The $3,616 reported for 2025 was more than what 93% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $125 · 2022: $223 · 2023: $906 · 2024: $121 · 2025: $3,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Travel and Lodging: $1,290 · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $1,289.94 |
| Food and Beverage | $602.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $4,521.54 | 2023-2025 | Elucirem |
| Ge Healthcare | $248.41 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $121.14 | 2024 | |
| Koelis INC. | $101.17 | 2019 | |
| Ethicon US, LLC | $100.00 | 2022 | |
| Astellas Pharma US INC | $70.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Margolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.